Cardiovascular risks of cyclooxygenase-2 inhibitors: Where we stand now

被引：32

作者：

Finckh, A

Aronson, MD

机构：

[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA 02115 USA

[2] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA

来源：

ANNALS OF INTERNAL MEDICINE | 2005年 / 142卷 / 03期

关键词：

D O I：

10.7326/0003-4819-142-3-200502010-00013

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

The authors believe that cyclooxygenase-2 (COX-2) inhibitors, in particular at higher dosages and for longer-term use, should not be a first-line therapy for patients who can tolerate alternative therapies. We urgently need further research to document the safety of long-term use of COX-2 inhibitors and nonselective nonaspirin nonsteroidal anti-inflammatory drugs.

引用

页码：212 / 214

页数：3

共 22 条

[1]

ABELSON R, 2004, NY TIMES, pB1

[2]

Efficacy assessment of meloxicam, a preferential cyclooxygenase-2 inhibitor, in acute coronary syndromes without ST-segment elevation - The nonsteroidal anti-inflammatory drugs in unstable angina treatment-2 (NUT-2) pilot study [J].

Altman, R ;

Luciardi, HL ;

Muntaner, J ;

Del Rio, F ;

Berman, SG ;

Lopez, R ;

Gonzalez, C .

CIRCULATION, 2002, 106 (02) :191-195

[3]

*ASS PRESS, CONC RAIS NAPR ALZH

[4]

Bolten WW, 1998, J RHEUMATOL, V25, P2

[5]

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. [J].

Bombardier, C ;

Laine, L ;

Reicin, A ;

Shapiro, D ;

Burgos-Vargas, R ;

Davis, B ;

Day, R ;

Ferraz, MB ;

Hawkey, CJ ;

Hochberg, MC ;

Kvien, TK ;

Schnitzer, TJ ;

Weaver, A .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (21) :1520-1528

[6]

BURKLOW J, 2004, NIH HALTS USE COX 2

[7]

Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. [J].

Catella-Lawson, F ;

Reilly, MP ;

Kapoor, SC ;

Cucchiara, AJ ;

DeMarco, S ;

Tournier, B ;

Vyas, SN ;

FitzGerald, GA .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (25) :1809-1817

[8]

Selective COX-2 inhibition improves endothelial function in coronary artery disease [J].

Chenevard, R ;

Hürlimann, D ;

Béchir, M ;

Enseleit, F ;

Spieker, L ;

Hermann, M ;

Riesen, W ;

Gay, S ;

Gay, RE ;

Neidhart, M ;

Michel, B ;

Lüscher, TF ;

Noll, G ;

Ruschitzka, F .

CIRCULATION, 2003, 107 (03) :405-409

[9]

GRAHAM DJ, 2004, PHARMACOEPIDEM DR S, V13, pS287

[10]

Differential effects of selective cyclooxygenase-2 inhibitors on endothelial function in salt-induced hypertension [J].

Hermann, M ;

Camici, G ;

Fratton, A ;

Hurlimann, D ;

Tanner, FC ;

Hellermann, JP ;

Fiedler, M ;

Thiery, J ;

Neidhart, M ;

Gay, RE ;

Gay, S ;

Lüscher, TF ;

Ruschitzka, F .

CIRCULATION, 2003, 108 (19) :2308-2311

← 1 2 3 →